MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts

Human Pathology

Volumn 29, Issue 2, 1998, Pages 155-165

  Afzal, Saliha ^b   Lalani, El Nasir ^b   Poulsom, Richard ^b   Stubbs, Andrew ^b   Rowlinson, Gail ^b   Sato, Hiroshi ^b   Seiki, Motoharu ^b   Stamp, Gordon W H ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Desmoplasia; Fibroblast; Invasion; Matrix metalloproteinase; MMP 2; MT1 MMP; Ovarian; Remodeling; Stroma; Xenograft

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOUSE; OVARY CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA ANALYSIS; TISSUE DISTRIBUTION;

EID: 0031909775     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90226-X     Document Type: Article

References (53)

1. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 14:455-463, 1992
2. Murphy G, Houbrechts A, Cockett MI, et al: The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30:8097-8102, 1991
3. Goldberg GI, Marmer BL, Grant GA, et al: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86:8207-8211, 1989
4. Will H, Atkinson SJ, Butler GS, et al: The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation: Regulation by TIMP-2 and TIMP-3. J Biol Chem 271:17119-17123, 1996
5. Liotta LA, Stetler Stevenson WG: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 51:5054s-5059s, 1991
6. Tryggvason K, Hoyhtya M, Pyke C: Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24:209-218, 1993
7. Brown PD, Bloxidge RE, Stuart NS, et al: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non small-cell lung carcinoma. J Natl Cancer Inst 85:574-578, 1993
8. Davies B, Miles DW, Happerfield LC, et al: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67:1126-1131, 1993
9. Emmert Buck MR, Roth MJ, Zhuang Z, et al: Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145:1285-1290, 1994
10. Poulsom R, Pignatelli M, Stetler Stevenson WG, et al: Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389-396, 1992
11. Poulsom R, Hanby AM, Pignatelli M, et al: Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46:429-436, 1993
12. Pyke C, Ralfkiaer E, Huhtala P, et al: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52:1336-1341, 1992
13. Afzal S, Lalani E-N, Foulkes WD, et al: Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumour cell lines. Lab Invest 74:406-421, 1996
14. Campo E, Merino MJ, Tavassoli FA, et al: Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol 16:500-507, 1992
15. Stetler Stevenson WG, Liotta LA, Kleiner DE Jr: Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434-1441, 1993
16. Lewalle JM, Munaut C, Pichot B, et al: Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol 165:475-483, 1995
17. Emonard HP, Remade AG, Noel AC, et al: Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res 52:5845-5848, 1992
18. Emmert Buck MR, Emonard HP, Corcoran ML, et al: Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett 364:28-32, 1995
19. Brooks PC, Stromblad S, Sanders LC, et al: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683-693, 1996
20. Brooks PC, Stromblad S, Klemke R, et al: Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96:1815-1822, 1995
21. Felding Habermann B, Mueller BM, Romerdahl CA, et al: Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. J Clin Invest 89:2018-2220, 1992
22. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65, 1994
23. Okada A, Bellocq JP, Rouyer N, et al: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734, 1995
24. Will H, Hinzmann B: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231:602-608, 1995
25. Takino T, Sato H, Shinagawa A, et al: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library: MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 270:23013-23020, 1995
26. Puente XS, Pendas AM, Llano E, et al: Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949, 1996
27. Gilles C, Polette M, Piette J, et al: High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65:209-213, 1996
28. Yamamoto M, Mohanam S, Sawaya R, et al: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384-392, 1996
29. Atkinson SJ, Crabbe T, Cowell S, et al: Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270:30479-30485, 1995
30. Sato H, Takino T, Kinoshita T, et al: Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrixmetalloproteinase (MT1-MMP). FEBS Lett 385:238-240, 1996
31. Strongin AY, Collier I, Bannikov G, et al: Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338, 1995
32. Yu M, Sato H, Seiki M, et al: Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55:3272-3277, 1995
33. Ohtani H, Motohashi H, Sato H, et al: Dual over expression pattern of membrane type metalloproteinase 1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int J Cancer 68:565-570, 1996
34. Foulkes WD, Ragoussis J, Stamp GW, et al: Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 67:551-559, 1993
35. Senior PV, Critchley DR, Beck F, et al: The localization of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: An in situ hybridization and immunocytochemical study. Development 104:431-446, 1988
36. Naylor MS, Stamp GW, Foulkes WD, et al: Tumor necrosis factor and its receptors in human ovarian cancer: Potential role in disease progression. J Clin Invest 91:2194-2206, 1993
37. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
38. Autio-Harmainen H, Karttunen T, Hurskainen T, et al: Expression of 72 kilodalton type TV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 69:312-321, 1993
39. Naylor MS, Stamp GW, Davies BD, et al: Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58:50-56,1994
40. Gregoire M, Lieubeau B: The role of fibroblasts in tumor behavior. Cancer Metastasis Rev 14:339-350, 1995
41. Young TN, Rodriguez GC, Rinehart AR, et al: Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: Purification of matrix metalloproteinase 2. Gynecol Oncol 62:89-99, 1996
42. Polette M, Nawrocki B, Gilles C, et al: MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch 428:29-35, 1996
43. Heppner KJ, Matrisian LM, Jensen RA, et al: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149:273-282, 1996
44. Tokuraku M, Sato H, Murakami S, et al: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64:355-359, 1995
45. Nomura H, Sato H, Seiki M, et al: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55:3263-3266, 1995
46. MacDougall JR, Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14:351-362, 1995
47. Wright JH, McDonnell S, Portella G, et al: A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog 10:207-215, 1994
48. MacDougall JR, Bani MR, Lin Y, et al: The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55:4174-4181, 1995
49. Auersperg N, Maines Bandiera SL, Dyck HG, et al: Characterization of cultured human ovarian surface epithelial cells: Phenotypic plasticity and premalignant changes. Lab Invest 71:510-518, 1994
50. Basset P, Bellocq JP, Wolf C, et al: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990
51. Imai K, Ohuchi E, Aoki T, et al: Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56:2707-2710, 1996
52. Cao J, Sato H, Takino T, et al: The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270:801-805, 1995
53. Kinoshita T, Sato H, Takino T, et al: Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 56:2535-2538, 1996